Cargando…
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro
Because rare, but severe adverse effects, i.e. retinal vasculitis or retinal vein occlusion, have been observed after repetitive intravitreal injections of VEGF-A-binding single-chain variable fragment brolucizumab (Beovu), we investigated its possible impact on the barrier formed by immortalized bo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304347/ https://www.ncbi.nlm.nih.gov/pubmed/35864147 http://dx.doi.org/10.1038/s41598-022-16770-7 |